AGL 38.00 No Change ▼ 0.00 (0%)
AIRLINK 213.91 Increased By ▲ 3.53 (1.68%)
BOP 9.42 Decreased By ▼ -0.06 (-0.63%)
CNERGY 6.29 Decreased By ▼ -0.19 (-2.93%)
DCL 8.77 Decreased By ▼ -0.19 (-2.12%)
DFML 42.21 Increased By ▲ 3.84 (10.01%)
DGKC 94.12 Decreased By ▼ -2.80 (-2.89%)
FCCL 35.19 Decreased By ▼ -1.21 (-3.32%)
FFBL 88.94 No Change ▼ 0.00 (0%)
FFL 16.39 Increased By ▲ 1.44 (9.63%)
HUBC 126.90 Decreased By ▼ -3.79 (-2.9%)
HUMNL 13.37 Increased By ▲ 0.08 (0.6%)
KEL 5.31 Decreased By ▼ -0.19 (-3.45%)
KOSM 6.94 Increased By ▲ 0.01 (0.14%)
MLCF 42.98 Decreased By ▼ -1.80 (-4.02%)
NBP 58.85 Decreased By ▼ -0.22 (-0.37%)
OGDC 219.42 Decreased By ▼ -10.71 (-4.65%)
PAEL 39.16 Decreased By ▼ -0.13 (-0.33%)
PIBTL 8.18 Decreased By ▼ -0.13 (-1.56%)
PPL 191.66 Decreased By ▼ -8.69 (-4.34%)
PRL 37.92 Decreased By ▼ -0.96 (-2.47%)
PTC 26.34 Decreased By ▼ -0.54 (-2.01%)
SEARL 104.00 Increased By ▲ 0.37 (0.36%)
TELE 8.39 Decreased By ▼ -0.06 (-0.71%)
TOMCL 34.75 Decreased By ▼ -0.50 (-1.42%)
TPLP 12.88 Decreased By ▼ -0.64 (-4.73%)
TREET 25.34 Increased By ▲ 0.33 (1.32%)
TRG 70.45 Increased By ▲ 6.33 (9.87%)
UNITY 33.39 Decreased By ▼ -1.13 (-3.27%)
WTL 1.72 Decreased By ▼ -0.06 (-3.37%)
BR100 11,881 Decreased By -216 (-1.79%)
BR30 36,807 Decreased By -908.3 (-2.41%)
KSE100 110,423 Decreased By -1991.5 (-1.77%)
KSE30 34,778 Decreased By -730.1 (-2.06%)

KARACHI: As Pakistan’s pharmaceutical sector aims to leverage its potential for increased exports, industry experts are calling for government support to create an enabling environment for growth.

Key officials express that with the right policy framework, exports could rise dramatically from the current levels. Industry leaders pointed out that while sectors such as textiles, carpets, leather, sports goods, and surgical instruments receive preferential treatment, pharmaceuticals have not enjoyed similar benefits.

The current export facilitation framework appears to favour established sectors based on past performance, overlooking the substantial potential of pharmaceuticals, which could significantly contribute to foreign exchange inflows.

Pakistan Pharma Summit 2024: experts gather with aim to chart path for growth in pharmaceutical industry

Currently, Pakistan’s pharmaceutical industry has performed well in specific markets. Countries like Uzbekistan, Nigeria, and Afghanistan are among those where pharmaceuticals rank as major export commodities.

“Even based on existing performance, there are several countries where pharmaceutical products from Pakistan are the largest exported commodity,” underscoring the sector’s robust international footprint.

A former chairman of the Pakistan Pharmaceutical Manufacturers’ Association (PPMA) has already stated that the country’s pharmaceutical exports could reach $3 billion within the next five years if the government prioritises the sector in its export policies. In contrast, Indian pharmaceutical exports were projected to hit $28 billion, while Pakistan’s exports hit a historic high of just over $341 million in 2023-24.

Experts believed that a structured market development assistance (MDA) programme similar to India’s initiative could provide necessary support to local pharmaceutical companies.

Furthermore, they advocated for a thorough assessment of local API production capabilities before imposing duties, arguing that such measures can ensure affordability and competitiveness of Pakistani pharmaceutical products. The sector also faces challenges related to maintaining a stable supply chain and reliable raw material procurement, which are key to securing lasting agreements in foreign markets. As observed, foreign markets typically demand long-term contracts of up to seven years, creating a need for predictability in supply chains and procurement strategies.

With the government exploring avenues to generate foreign exchange and reduce dependency on debt, focusing on non-debt creating exports is critical. Analysts point out that despite significant rupee depreciation over recent years, the anticipated growth in exports has not materialized, suggesting that new strategies are necessary to unlock Pakistan’s export potential.

Copyright Business Recorder, 2024

Comments

Comments are closed.

Obaid Ali Nov 13, 2024 08:43pm
Functioning based on the incorrect hypothesis would be wrong. Don't be victim of ignorant. First and last word is Quality. No body ask anybody to manufacture poor quality drug. Be honest please
thumb_up Recommended (0)